Sign inStart free

Information Technology · Calculating & Accounting Machines (No Electronic Computers)

DBD DIEBOLD NIXDORF, Inc SEC Filings & Insider Trading Activity 2026

company
CIK 2882392 filings
Russell 2000
Follow DBD for alertsAsk AI about DBD

DBD at a glance

DIEBOLD NIXDORF, Inc (DBD, SEC CIK 28823) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on July 29, 2026, an 8-K current report on July 29, 2026 and Form 4 insider filings as recently as July 31, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), DIEBOLD NIXDORF, Inc (DBD) reported revenue of $3.8 billion (up 1.5% from FY2024) and net income of $94.6 million. Diluted EPS was $2.54.
  • As of June 30, 2026, 31 institutional investment managers tracked by SignalX reported holding DIEBOLD NIXDORF, Inc (DBD) shares worth $975.4 million in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by Timko Thomas S on July 31, 2026 of 700 shares at $72.29 per share.
  • In the last 90 days, DBD insiders reported 1 open-market purchase ($51K) and 0 open-market sales ($0) on Form 4, a net purchase of $51K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$3.8B
+1.5% vs prior year
Insiders · 90 days
1 buy · 0 sells
Net +$51K
13F holders
31 funds
$975.4M · +1 vs prior quarter
Latest 8-K
Jul 29, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Jun 30, 2026

Risk Factors

  • No risk factors provided in the submitted excerpt
  • Risk-factor changes cannot be assessed from available text

AI summary of the DBD 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Jul 29, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 revenue $930.8M, up 1.7% YoY, with Retail revenue up more than 20% for the second consecutive quarter
  • Adjusted EBITDA $120.6M, up 8.5% YoY, with margin expanding to 13.0% from 12.2%

Item 2.02: Results of Operations and Financial Condition

  • Q2 2025 results announced July 29, 2026, indicating a reporting-period/date mismatch requiring investor review
  • Full operating results, financial condition, and management commentary contained in Exhibit 99.1
Filed May 26, 2026Full analysis →

Item 5.07: Submission of Matters to a Vote of Security Holders

  • All eight director nominees elected to one-year terms, preserving board continuity
  • KPMG LLP appointment ratified for 2026 with 32,979,489 votes for
Filed Apr 30, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q1 2025 results announced April 30, 2026
  • Exhibit 99.1 contains the earnings release and financial details

Item EX-99.1: Item EX-99.1

  • Q1 revenue $891.8M, up 6.0% YoY, with Retail revenue up 26.5% offsetting Banking decline of 0.8%
  • Adjusted EBITDA $99.1M, up 13.5%, with margin expanding to 11.2% from 10.4%

AI summaries of DBD 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for DBD

Don't miss the next DBD filing

  • Alerts as it files. A push when DBD files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut DBD, by share count.
  • Ask anything. An AI agent that reads every DBD filing and answers with sources.
Follow DBD for alertsAsk AI about DBD
Compare plans →

DBD alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Timko Thomas SBuyJul 31, 2026$72.29
Millstreet Capital Management LLCSellJun 26, 2026$84.80
Millstreet Capital Management LLCSellJun 25, 2026$85.06
Millstreet Capital Management LLCSellJun 24, 2026$83.95
Millstreet Capital Management LLCSellJun 15, 2026$83.91
Millstreet Capital Management LLCSellJun 12, 2026$82.12
Millstreet Capital Management LLCSellJun 11, 2026$82.06
Millstreet Capital Management LLCSellJun 10, 2026$82.08
Insider trades across all companies →Which insider buys matter →

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$3.8B$3.8B
Gross Profit$520.0M$920.0M$961.2M
Operating Income-$182.1M$242.0M
Net Income$1.4B-$16.5M$94.6M
Gross Margin-24.5%25.3%
Op. Margin-4.9%6.4%
Net Margin--0.4%2.5%
Balance Sheet
Total Assets$4.2B$3.5B$3.9B
Equity-$929.8M$1.1B
ROE--1.8%8.6%
Per Share
EPS$16.69$-0.44$2.54
Cash Flow
Operating CF-$149.2M$300.7M

Source: XBRL data in DIEBOLD NIXDORF, Inc (DBD)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q2 2026

Aggregate DBD share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
DBD shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q2 202631$975.4M
Q1 202630$573.0M
Q4 202526$509.6M
Q3 202526$418.4M
Q2 202525$384.1M
Q1 202521$195.6M
Q4 202415$169.2M
Q3 202413$73.9M
Position changes: Q1 2026 → Q2 2026
Top Buyers
Top Sellers
New Positions
Closed Positions
None this quarter.

Source: 13F-HR filings on SEC EDGAR (aggregated from 187 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

DBD filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

10-Q quarterly reports

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Jul 31, 2026--
8-KJul 29, 2026Analysis-
10-QJul 29, 2026Analysis
4Jun 30, 2026--
4Jun 26, 2026--
4Jun 16, 2026--
4Jun 12, 2026--
4Jun 10, 2026-
4Jun 4, 2026-
4May 27, 2026-
8-KMay 26, 2026Analysis
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
8-KApr 30, 2026Analysis-
10-QApr 30, 2026Analysis
4Apr 17, 2026--
4Apr 10, 2026--
4Mar 17, 2026--
4Mar 9, 2026--
4Mar 9, 2026--
4Mar 3, 2026--
4Mar 3, 2026--
4Mar 3, 2026--

Related Information Technology companies

All Information Technology →

DBD SEC filings: frequently asked questions

Are DBD insiders buying or selling?

In the last 90 days, DIEBOLD NIXDORF, Inc (DBD) officers, directors and 10% owners reported 1 open-market purchase worth $50,603 by 1 insider and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold DBD stock?

As of June 30, 2026, the largest DIEBOLD NIXDORF, Inc (DBD) holders among the 13F filers tracked by SignalX were BlackRock ($387.2 million), Dimensional Fund Advisors ($110.2 million), State Street Corp ($97.0 million), Vanguard Capital Management LLC ($96.7 million), Vanguard Portfolio Management LLC ($81.3 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was DBD's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), DIEBOLD NIXDORF, Inc (DBD) reported revenue of $3.8 billion (up 1.5% from FY2024) and net income of $94.6 million. Diluted EPS was $2.54. The figures come from the XBRL data in the 10-K.

What did DBD report in its latest 8-K?

DIEBOLD NIXDORF, Inc (DBD) filed an 8-K on July 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 revenue $930.8M, up 1.7% YoY, with Retail revenue up more than 20% for the second consecutive quarter.

What are the latest DBD SEC filings?

DIEBOLD NIXDORF, Inc (DBD) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on July 29, 2026, an 8-K current report on July 29, 2026 and a Form 4 insider filing on July 31, 2026.

What is DBD's SEC CIK number?

DIEBOLD NIXDORF, Inc (DBD)'s SEC Central Index Key (CIK) is 28823. EDGAR lists every DBD filing under that number.

Ask anything about DBD

The research agent reads DBD's filings, financials, insider trades and 13F holders, then answers with sources.

Start free